JP2019070023A5 - - Google Patents

Download PDF

Info

Publication number
JP2019070023A5
JP2019070023A5 JP2019004688A JP2019004688A JP2019070023A5 JP 2019070023 A5 JP2019070023 A5 JP 2019070023A5 JP 2019004688 A JP2019004688 A JP 2019004688A JP 2019004688 A JP2019004688 A JP 2019004688A JP 2019070023 A5 JP2019070023 A5 JP 2019070023A5
Authority
JP
Japan
Prior art keywords
group
alkoxy
alkyl
substituted
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019004688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019070023A (ja
JP6868650B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019070023A publication Critical patent/JP2019070023A/ja
Publication of JP2019070023A5 publication Critical patent/JP2019070023A5/ja
Application granted granted Critical
Publication of JP6868650B2 publication Critical patent/JP6868650B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019004688A 2015-09-18 2019-01-15 ビアリール誘導体及びそれを含有する医薬 Active JP6868650B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015185966 2015-09-18
JP2015185966 2015-09-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017539924A Division JP6469238B2 (ja) 2015-09-18 2016-09-14 ビアリール誘導体及びそれを含有する医薬

Publications (3)

Publication Number Publication Date
JP2019070023A JP2019070023A (ja) 2019-05-09
JP2019070023A5 true JP2019070023A5 (enExample) 2019-10-24
JP6868650B2 JP6868650B2 (ja) 2021-05-12

Family

ID=58289324

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017539924A Active JP6469238B2 (ja) 2015-09-18 2016-09-14 ビアリール誘導体及びそれを含有する医薬
JP2019004688A Active JP6868650B2 (ja) 2015-09-18 2019-01-15 ビアリール誘導体及びそれを含有する医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017539924A Active JP6469238B2 (ja) 2015-09-18 2016-09-14 ビアリール誘導体及びそれを含有する医薬

Country Status (18)

Country Link
US (1) US10647675B2 (enExample)
EP (1) EP3351533B1 (enExample)
JP (2) JP6469238B2 (enExample)
KR (1) KR20180052635A (enExample)
CN (1) CN108290838B (enExample)
AR (1) AR106047A1 (enExample)
AU (1) AU2016325143B2 (enExample)
BR (1) BR112018004447A2 (enExample)
CA (1) CA2997537C (enExample)
ES (1) ES3039645T3 (enExample)
IL (1) IL258160B (enExample)
MX (1) MX381444B (enExample)
MY (1) MY195201A (enExample)
PH (1) PH12018500434A1 (enExample)
RU (1) RU2760373C2 (enExample)
SG (1) SG11201801856XA (enExample)
TW (1) TWI730002B (enExample)
WO (1) WO2017047602A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017047602A1 (ja) * 2015-09-18 2017-03-23 科研製薬株式会社 ビアリール誘導体及びそれを含有する医薬
CN108727404B (zh) * 2017-04-14 2020-05-12 中国科学院上海药物研究所 噻吩并[3,2-d]嘧啶类化合物、其制备方法及用途
CA3081163A1 (en) 2017-10-30 2019-05-09 Kaken Pharmaceutical Co., Ltd. External preparation for treating trichophytosis unguium
AU2019390907B2 (en) * 2018-11-30 2025-05-08 Otsuka Pharmaceutical Co., Ltd. Heterocyclic compounds for the treatment of epilepsy
JP2021187859A (ja) * 2020-05-29 2021-12-13 大塚製薬株式会社 複素環化合物の医薬用途
BR112022024394A2 (pt) * 2020-06-04 2023-01-31 Bayer Ag Heterociclil pirimidinas e triazinas como novos fungicidas
WO2023027162A1 (ja) * 2021-08-27 2023-03-02 科研製薬株式会社 2-(4-エチルフェノキシ)-4'-メトキシ-3,3'-ビピリジンの結晶及びその製造方法
WO2023146512A1 (en) * 2022-01-25 2023-08-03 Vivace Therapeutics, Inc. Compounds and methods of use thereof
WO2023146511A1 (en) * 2022-01-25 2023-08-03 Vivace Therapeutics, Inc. Compounds and methods of use thereof
WO2024129896A1 (en) * 2022-12-14 2024-06-20 The Regents Of The University Of California Inhibitors of procaspase-6 activation and uses thereof
EP4634158A2 (en) * 2022-12-14 2025-10-22 The Regents of University of California Inhibitors of procaspase-6 activation and uses thereof

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505651D0 (en) * 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
MX9708802A (es) * 1995-05-17 1998-02-28 Du Pont Amidas ciclicas fungicidas.
AU2001285774A1 (en) 2000-06-23 2002-01-02 Basf Aktiengesellschaft Enhancement of the activity of carotenoid biosynthesis inhibitor herbicides
DE10038019A1 (de) * 2000-08-04 2002-02-14 Bayer Ag Substituierte Triazolopyrid(az)ine
AU2003274025A1 (en) * 2002-10-17 2004-05-04 Syngenta Participations Ag Pyridine derivatives useful as herbicides
AU2003293376A1 (en) * 2002-12-10 2004-06-30 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
WO2004078756A2 (en) 2003-03-06 2004-09-16 Eisai Co., Ltd. Jnk inhibitors
WO2004080972A1 (en) 2003-03-12 2004-09-23 Vertex Pharmaceuticals Incorporated Pirazole modulators of atp-binding cassette transporters
US7880000B2 (en) * 2004-05-07 2011-02-01 Amgen Inc. Protein kinase modulators and method of use
ATE499370T1 (de) 2005-01-19 2011-03-15 Bristol Myers Squibb Co 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3- aminderivate und verwandte verbindungen als p2y1- rezeptor-hemmer zur behandlung thromboembolischer erkrankungen
JP2008540656A (ja) 2005-05-18 2008-11-20 ワイス Tpl2キナーゼの3−シアノキノリン阻害物質ならびにそれを製造および使用する方法
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
RU2380365C1 (ru) * 2005-10-31 2010-01-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Гетероциклические замещенные производные пиримидина и содержащий их противогрибковый агент
CA2637658C (en) 2006-01-23 2012-07-17 Amgen Inc. Aurora kinase modulators and method of use
US7868177B2 (en) 2006-02-24 2011-01-11 Amgen Inc. Multi-cyclic compounds and method of use
MX2009003222A (es) 2006-10-04 2009-04-06 Hoffmann La Roche Derivados de 3-piridinocarboxamida y 2-pirazinocarboxamida como agentes elevadores de colesterol de lipoproteina de alta densidad.
WO2008057280A1 (en) 2006-10-27 2008-05-15 Amgen Inc. Multi-cyclic compounds and methods of use
WO2008135824A1 (en) 2007-05-02 2008-11-13 Pfizer Limited Oxyalkylpyrazole compounds useful in therapy
CN101952275B (zh) 2008-02-22 2014-06-18 弗·哈夫曼-拉罗切有限公司 β-淀粉样蛋白的调节剂
TWI396689B (zh) * 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物
AR074343A1 (es) 2008-11-14 2011-01-12 Amgen Inc Derivados de piridina y pirimidina como inhibidores de la fosfodiesterasa 10
ES2397934T3 (es) 2008-12-17 2013-03-12 Amgen Inc. Compuestos de aminopiridina y carboxipiridina como inhibidores de fosfodiesterasa 10
UY32582A (es) * 2009-04-28 2010-11-30 Amgen Inc Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
CA2771190C (en) 2009-08-17 2020-01-21 Memorial Sloan-Kettering Cancer Center Heat shock protein binding compounds, compositions, and methods for making and using same
KR101301533B1 (ko) * 2010-02-09 2013-09-04 한미사이언스 주식회사 암세포 성장 억제 효과를 갖는 신규 피리미딘 유도체
CA2800998A1 (en) * 2010-04-29 2011-11-10 Deciphera Pharmaceuticals, Llc Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
WO2011161201A1 (en) 2010-06-22 2011-12-29 Kancera Ab Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
US8906943B2 (en) 2010-08-05 2014-12-09 John R. Cashman Synthetic compounds and methods to decrease nicotine self-administration
EP2630136A1 (en) 2010-10-21 2013-08-28 Universität des Saarlandes Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
JP5937102B2 (ja) 2010-12-14 2016-06-22 エレクトロフォレティクス リミテッド カゼインキナーゼ1デルタ(ck1デルタ)阻害剤
SG10201604682VA (en) 2011-06-10 2016-07-28 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
PT2573073E (pt) 2011-09-26 2015-02-05 Sanofi Sa Derivados de pirazoloquinolinona, sua preparação e sua utilização terapêutica
US20140235616A1 (en) 2011-09-26 2014-08-21 Sanofi Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
JP5729889B2 (ja) 2011-10-17 2015-06-03 日本曹達株式会社 含窒素ヘテロ環化合物および農園芸用殺菌剤
TW201329067A (zh) 2011-12-08 2013-07-16 Amgen Inc 作為gka活化劑之脲化合物
RU2592554C2 (ru) 2011-12-14 2016-07-27 Зингента Партисипейшнс Аг Фунгицидные композиции
CN105230625A (zh) * 2011-12-14 2016-01-13 先正达参股股份有限公司 杀真菌组合物
CN104797555B (zh) 2012-07-06 2017-12-22 基因泰克公司 N‑取代的苯甲酰胺及其使用方法
WO2013171729A2 (en) 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl amide compounds as rorgamat modulator
CA3082427A1 (en) 2013-03-15 2014-09-25 Purdue Pharma L.P. Carboxamide derivatives and use thereof
WO2016007534A1 (en) 2014-07-07 2016-01-14 Genentech, Inc. Therapeutic compounds and methods of use thereof
JPWO2016098793A1 (ja) 2014-12-17 2017-09-28 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体
CN108026050B (zh) 2015-08-03 2021-04-30 格兰马克药品股份有限公司 作为RORγ调节剂的新型化合物
WO2017047602A1 (ja) * 2015-09-18 2017-03-23 科研製薬株式会社 ビアリール誘導体及びそれを含有する医薬

Similar Documents

Publication Publication Date Title
JP2019070023A5 (enExample)
JP2005525392A5 (enExample)
JP2012092103A5 (enExample)
JP2011507813A5 (enExample)
RU2018119344A (ru) Конденсированные бициклические гетероциклические производные в качестве средства для борьбы с вредителями
JP2013517278A5 (enExample)
JP2018533580A5 (enExample)
JP2014515349A5 (enExample)
JP2009544635A5 (enExample)
JP2016503793A5 (enExample)
JP2014507459A5 (enExample)
JP2010504286A5 (enExample)
JP2016540742A5 (enExample)
JP2016506369A5 (enExample)
JP2015531773A5 (enExample)
JP2013536856A5 (enExample)
RU2016122104A (ru) Новые соединения для борьбы с членистоногими
RU2013141413A (ru) Производные изоксазолина для борьбы с беспозвоночными паразитами
JP2018536681A5 (enExample)
JP2009507896A5 (enExample)
JP2016530310A5 (enExample)
JP2016501185A5 (enExample)
JP2013129675A5 (enExample)
JP2014177467A5 (enExample)
RU2008143018A (ru) 5(гидроксиметилен-и аминометилен)замещенные пиримидины, ингибирующие вич